A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion

Figure 3

Immunohistochemistry findings of TFE3. (a–d) The tumor cells were diffusely and strongly positive (+++) for CD10, SDHB, vimentin, and PAX8. (e) The tumor cells were negative for cathepsin K. (f) TFE3 showed an uncertainly weak nuclear staining (1+); the upper right corner was the positive control.

(a)

(b)

(c)

(d)

(e)

(f)